Search Within

Samantha Brown

  1. "Sean Devlin"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (9)
  3. Research Letter (2)
Groups
  1. Biostatistics Service (25)
  2. Epidemiology and Biostatistics (25)
  3. Bone Marrow Transplant (24)
  4. Center for Hematologic Malignancies (24)
  5. Department of Medicine (24)
  6. Hematologic Malignancies, Division of (24)

More Groups

People
  1. Sean Devlin (25)
  2. Miguel-Angel Perales (17)
  3. Brian Shaffer (12)
  4. Gunjan Shah (11)
  5. Sergio Giralt (11)
  6. Michael Scordo (10)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (7)
  4. 2022 (5)
  5. 2021 (2)
Publications
  1. Blood (9)
  2. Blood Advances (4)
  3. Transplantation and Cellular Therapy (3)
  4. British Journal of Haematology (2)
  5. American Journal of Hematology (1)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Elsevier Inc. (3)
  3. John Wiley & Sons (2)
  4. American Association for Cancer Research (1)
  5. Harborside Press (1)
  6. John Wiley & Sons, Inc. (1)

More Publishers

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET-based biomarkers for toxicity prediction in CAR T-cell therapy for aggressive lymphoma: Evidence from a large-scale retrospective analysis
    Meeting Abstract

    Ucpinar, B. A.; Brown, S.; Bedmutha, A.; Leithner, D.; Raj, S.; Devlin, S.; Shah, G.; Perales, M. A.; Shouval, R.; Schoder, H.
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience
    Journal Article

    Cassanello, G.; Luttwak, E.; Brown, S.; Devlin, S. M.; Imber, B.; Ip, A.; Leslie, L. A.; Accav, N. G.; Avigdor, A.; Marcus, R.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • CAR T-cell therapy for DLBCL with CNS involvement: Overall safe and effective with limited efficacy in patients with leptomeningeal disease
    Meeting Abstract

    Luttwak, E.; Cassanello, G.; Brown, S.; Devlin, S. M.; Imber, B. S.; Ip, A.; Leslie, L. A.; Accav, N. G.; Beyar-Katz, O.; Corona, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses
    Meeting Abstract

    Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase II study of longitudinal geriatric assessment with risk-adapted interventions to reduce non-relapse mortality in allogeneic hematopoietic cell transplantation for older patients with advanced myeloid malignancies
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Brown, S.; Hanley, D. M.; Engstler, D. E.; Politikos, I.; Gyurkocza, B.; Tamari, R.; Papadopoulos, E. B.; Saldia, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
    Journal Article

    Shaffer, B. C.; Brown, S.; Chinapen, S.; Mangold, K. E.; Lahoud, O.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; Giralt, S.; Devlin, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation
    Journal Article

    Fingrut, W. B.; Davis, E.; Archer, A.; Brown, S.; Devlin, S.; Nhaissi, M.; Rapoport, C.; Chinapen, S.; Kelly, A.; Wells, D.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
    Research Letter

    Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save